Journal of Orthopaedic Nursing
Volume 9, Issue 2 , Pages 64-76 , May 2005

Immunogenetics and rheumatoid arthritis: A review for orthopaedic nurses

  • James A. Rankin, RN, RNT, ACNP, BSc (Hons), MSc, PhD (Associate Professor and Acute Care Nurse Practitioner)

      Affiliations

    • Corresponding Author InformationTel.: +1 403 220 2732; fax: +1 403 284 4803

References 

  1. Amar A, Oksenberg J, Cohen N, Cohen I, Brautbar C. HLA-D locus in Israel: characterization of 14 local HTC’s and a population study. Tissue Antigens. 1982;20(1):198–207
  2. Andersson EC, Svendsen P, Svejgaard A, Holmdahl R, Fugger L. A molecular basis for the HLA association in rheumatoid arthritis. Reviews in Immunogenetics. 2000;2(1):81–87
  3. Arend WP, Dayer JM. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis and Rheumatism. 1990;33(3):305–315
  4. Arend WP, Dayer JM. Inhibition of the effects and production of interleukin-1 and tumor necrosis factor a in rheumatoid arthritis. Arthritis and Rheumatism. 1995;38(1):151–160
  5. Arner EC, Pratta MA. Independent effects of interleukin-1 proteoglycan breakdown, proteoglycan synthesis, and prostaglandin E2 release from cartilage in organ culture. Arthritis and Rheumatism. 1989;33(4):542–552
  6. Arnett FC. HLA genes and predisposition to rheumatic diseases. Hospital Practice. 1986;21(12):89–100
  7. Austin CP. The impact of the completed human genome sequence on the development of novel therapeutics for human disease. Annual Review of Medicine. 2004;55(1):1–13
  8. Baboonian C, Venables PJ, Williams DG, Williams RD, Maini RN. Cross-reaction of antibodies to a glycine/alanine repeat sequence of Epstein-Barr virus nuclear antigen 1 with collagen, cytokeratin and actin. Annals of the Rheumatic Diseases. 1991;50(11):772–775
  9. Baird RW, Bronze MS, Kraus W, Hill HR, Veasey LG, Dale JB. Epitopes of group A streptococcal M protein shared with antigens of articular cartilage and synovium. Journal of Immunology. 1991;146:3132–3137
  10. Balkwill FR, Burke F. The cytokine network. Immunology Today. 1989;10(9):299–304
  11. Barton A, Eyre S, Myerscough A, Brintnell B, Ward D, Ollier WE, et al. High-resolution linkage and association mapping identifies a novel rheumatoid arthritis susceptibility locus homologous to one linked to two rat models of inflammatory arthritis. Human Molecular Genetics. 2001;10(18):1901–1906
  12. Blaschke S, Schulz H, Schwarz G, Blaschke V, Muller GA, Reuss-Borst M. Interleukin 16 expression in relation to disease activity in rheumatoid arthritis. Journal of Rheumatology. 2001;28(1):12–21
  13. Bodmer WF. HLA. In:  Dupont B editors. Immunobiology of HLA. vol. 2:New York: Springer; 1989;p. 220–245
  14. Boyle MDP, Reis KJ. Bacterial Fc receptors. Biotechnology. 1987;5:697–703
  15. Boyle LH, Goodall JC, Gaston JS. Major histocompatibility complex class I-restricted alloreactive CD4+ T cells. Immunology. 2004;112(1):54–63
  16. Braun WE. HLA molecules in autoimmune diseases. Clinical Biochemistry. 1992;25(3):187–191
  17. Breedveld FC. New insights in the pathogenesis of rheumatoid arthritis. Journal of Rheumatology. 1998;(Supplement 53):3–7
  18. Bottazzo GF, Locatelli M, Fierabracci A, Fruci D. The genetic basis of immune and autoimmune responses. Acta Paediatrica Supplement. 2004;93(445):38–42
  19. Buckley CD. Why does chronic inflammatory joint disease persist?. Clinical Medicine. 2003;3(4):361–366
  20. Burmester GR, Solback W. Hit and run, hit and hide or permanent hit: Why it is premature to dump Koch’s postulates in rheumatic diseases. Journal of Rheumatology. 1992;19(8):1173–1174
  21. Cohen IR. The self, the world and autoimmunity. Scientific American. 1988;258:52–60
  22. Cohen SB. The use of anakinra, an interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis. Rheumatic Diseases Clinics of North America. 2004;30(2):365–380
  23. Cooke T, Scudamore R. Studies in the pathogenesis of rheumatoid arthritis. British Journal of Rheumatology. 1989;30(5):370–372
  24. Crowther CL, Mourad LA. Alterations of musculoskeletal function. In:  McCance KL,  Huether SE editor. Pathophysiology: The basis for disease in adults and children. fourth ed.. Philadelphia, PA: C.V. Mosby; 2002;p. 1389–1393
  25. Cush JJ, Lipsky PE. Cellular basis for rheumatoid inflammation. Clinical Orthopaedics and Related Research. 1991;265:9–22
  26. Cyranoski D. Japan announces follow-up to human genome project. Nature. 2004;429(6990):332
  27. Detours V, Mehr R, Perelson AS. A quantitative theory of affinity-driven T cell repertoire selection. Journal of Theoretical Biology. 1999;200(4):389–403
  28. Dinarello CA. The IL-1 family and inflammatory diseases. Clinical and Experimental Rheumatology. 2002;20(5 Suppl. 27):S1–S13
  29. Durai M, Kim HR, Moudgil KD. The regulatory C-terminal determinants within mycobacterial heat shock protein 65 are cryptic and cross-reactive with the dominant self homologs: implications for the pathogenesis of autoimmune arthritis. Journal of Immunology. 2004;173(1):181–188
  30. Ebringer A, Wilson C. HLA molecules, bacteria and autoimmunity. Journal of Medical Microbiology. 2000;49(4):305–311
  31. Emery P, Seto Y. Role of biologics in early arthritis. Clinical and Experimental Rheumatology. 2003;21(5 Suppl. 31):S191–S194
  32. Fernandes JC, Martel-Pelletier J, Pelletier JP. The role of cytokines in osteoarthritis pathophysiology. Biorheology. 2002;39(1–2):237–246
  33. Fife MS, Fisher SA, John S, Worthington J, Shah CJ, Ollier WE, et al. Multipoints linkage analysis of a candidate gene locus in rheumatoid arthritis demonstrates significant evidence of linkage and association with the corticotropin-releasing hormone genomic region. Arthritis & Rheumatism. 2000;43(8):1673–1678
  34. Firestein GS. The T cell cometh: interplay between adaptive immunity and cytokine networks in rheumatoid arthritis. Journal of Clinical Investigation. 2004;114(4):471–474
  35. Firestein GS, Zvaifler NJ. How important are T cells in chronic rheumatoid synovitis?. Arthritis and Rheumatism. 1990;33(6):768–773
  36. Firestein GS, Tsai V, Zvaifler NJ. Cellular immunity in the joints of patients with rheumatoid arthritis and other forms of chronic synovitis. Rheumatic Disease Clinics of North America. 1987;13(2):91–213
  37. Ford DK. Synovial lymphocytes can indicate specific microbiologic causes of rheumatoid arthritis. Arthritis and Rheumatism. 1993;36(8):1350–1352
  38. Ford DK. Understanding rheumatoid arthritis. Journal of Rheumatology. 1997;24(7):1464–1466
  39. Frauendorf E, von Goessel H, May E, Marker-Hermann E. HLA-B27-restricted T cells from patients with ankylosing spondylitis recognize peptides from B*2705 that are similar to bacteria-derived peptides. Clinical and Experimental Immunology. 2003;134(2):351–359
  40. Gabriel SE. The epidemiology of rheumatoid arthritis. Rheumatic Diseases Clinics of North America. 2001;27(2):269–281
  41. Garcia F, Marina A, Albar JP, Lopez de Castro JA. HLA-B27 presents a peptide from a polymorphic region of its own molecule with homology to proteins from arthritogenic bacteria. Tissue Antigens. 1997;49(1):23–28
  42. Gaston JSH, Life PF, Van der Zee R, Jenner PJ, Colston MJ, Tonks S, et al. Epitope specificity and MHC restriction of rheumatoid arthritis T cell clones which recognize a mycobacterial 65 kDa heat shock protein. International Immunology. 1991;3(10):965–972
  43. Ghivizzani SC, Oligino TJ, Glorioso JC, Robbins PD, Evans CH. Gene therapy approaches for treating rheumatoid arthritis. Clinical Orthopaedics and Related Research. 2000;379(Suppl):S288–S299
  44. Gibert M, Sanchez-Mazas A. Geographic patterns of functional categories of HLA-DRB1 alleles: a new approach to analyse associations between HLA-DRB1 and disease. European Journal of Immunogenetics. 2003;30(5):361–374
  45. Glant TT, Finnegan A, Mikecz K. Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics. Critical Reviews in Immunology. 2003;23(3):199–250
  46. Gonzalez-Gay MA, Hajeer AH, Dababneh A, Makki R, Garcia-Porrua C, Thomson W, et al. Seronegative rheumatoid arthritis in elderly and polymyalgia rheumatica have similar patterns of HLA association. Journal of Rheumatology. 2001;28(1):122–125
  47. Gregersen PK. Biology of disease. HLA class II polymorphism: Implications for genetic susceptibility to autoimmune disease. Laboratory Investigation. 1989;61(1):5–9
  48. Gregersen PK. Genetics of rheumatoid arthritis: confronting complexity. Arthritis Research. 1999;1(1):37–44
  49. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. Arthritis and Rheumatism. 1987;30(11):1205–1213
  50. Grossman JM, Brahn E. Rheumatoid arthritis: current clinical and research directions. Journal of Women’s Health. 1997;6(6):627–638
  51. Guilherme L, Kalil J. Rheumatic fever: from sore throat to autoimmune heart lesions. International Archives of Allergy & Immunology. 2004;134(1):56–64
  52. Harris ED. Synovial inflammation in rheumatoid arthritis. Hospital Practice. 1986;21(9):71–82
  53. Harris ED. Rheumatoid arthritis: pathophysiology and implications for therapy. New England Journal of Medicine. 1990;322(18):1277–1280
  54. Holoshitz J, Matitiau A, Cohen IR. Arthritis induced in rats by cloned T lymphocytes to mycobacteria but not to collagen type II. Journal of Clinical Investigation. 1984;73(20):211–215
  55. Holoshitz J, Koning F, Coligan J, de Bruyn J, Strober S. Isolation of CD4–CD8 mycobacteria reactive T lymphocyte clones from rheumatoid arthritis synovial fluid. Nature. 1989;339(6221):226–229
  56. Husby G, Williams RC. Synovial localization of tumor necrosis factor in patients with rheumatoid arthritis. Journal of Autoimmunity. 1988;1(2):363–371
  57. Husby G, Tsuchiya N, Schwimmbeck PL, Keat A, Pahle JA, Oldstone MBA, et al. Cross-reactive epitope with Klebsiella pneumoniae nitrogenase in articular tissue of HLA-B27(+) patients with ankylosing spondylitis. Arthritis and Rheumatism. 1989;32(4):437–445
  58. Inman RD. Infectious etiology of rheumatoid arthritis. Rheumatic Disease Clinics of North America. 1991;17(4):859–870
  59. Iwanaga T, Shikichi M, Kitamura H, Yanase H, Nozawa-Inoue K. Morphology and functional roles of synoviocytes in the joint. Archives of Histology and Cytology. 2000;63(1):17–31
  60. Jasmin HE. Intra-articular antigen-antibody reactions. Rheumatic Disease Clinics of North America. 1987;13(2):179–189
  61. Kaplan MH. The cross-reaction of group A streptococci with heart tissue and its relation to induced autoimmunity in rheumatic fever. Bulletin on the Rheumatic Diseases. 1969;19(9):560–567
  62. Karr RW, Rodey GE, Lee T, Schwartz B. Association with HLA-DRw4 with rheumatoid arthritis in black and white patients. Arthritis and Rheumatism. 1980;23(11):1241–1245
  63. Kelso A. Cytokines: structure, function and synthesis. Current Opinion in Immunology. 1989;2(1):215–225
  64. Kirkham B. Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis. Annals of the Rheumatic Diseases. 1991;50(6):395–400
  65. Klimiuk PA, Yang H, Goronzy JJ, Weyand CM. Production of cytokines and metalloproteinases in rheumatoid synovitis is T cell dependent. Clinical Immunology. 1999;90(1):65–78
  66. Kong KF, Yeap SS, Chow SK, Phipps ME. HLA-DRB1 genes and susceptibility to rheumatoid arthritis in three ethnic groups from Malaysia. Autoimmunity. 2002;35(4):235–239
  67. Kuby J. Immunology. New York: W.H. Freeman; 1992;pp. 390–405
  68. Lafyatis R, Flipo RM, Duquesnoy B, Capron A. Antibodies in rheumatoid synovial fluids bind to a restricted series of protein antigens in rheumatoid synovial tissue. Arthritis and Rheumatism. 1992;35(9):1016–1027
  69. Lajeunesse D. The role of bone in the treatment of osteoarthritis. Osteoarthritis and Cartilage. 2004;12(Suppl. A):S34–S38
  70. Lanchbury JS. Molecular genetics of the HLA-D region component of inherited susceptibility to rheumatoid arthritis. British Journal of Rheumatology. 1988;27(2):171–175
  71. Lanchbury JS. The HLA association with rheumatoid arthritis. Clinical and Experimental Rheumatology. 1992;10(3):301–304
  72. Lanzavecchia A, Lezzi A, Viola A. From TCR engagement to T cell activation: A kinetic view of T cell behavior. Cell. 1999;96(1):1–4
  73. Larsen BA, Alderdice CA, Hawkins D, Martin JR, Mitchell DM, Sheridan DP. Protective HLA-DR phenotypes in rheumatoid arthritis. Journal of Rheumatology. 1989;16(4):455–458
  74. Malawista SE. Lyme disease. In:  McCarty DJ editors. Arthritis and allied conditions. 11th ed.. Philadelphia, PA: Lea & Febiger; 1989;p. 340–351
  75. Malemud CJ, Islam N, Haqqi TM. Pathophysiological mechanisms in osteoarthritis lead to novel therapeutic strategies. Cells Tissues Organs. 2003;174(1–2):34–48
  76. Martinez A, Salido M, Bonilla G, Pascual-Salcedo D, Fernandez-Arquero M, de Miguel S, et al. Association of the major histocompatibility complex with response to infliximab therapy in rheumatoid arthritis. Arthritis and Rheumatism. 2004;50(4):1077–1082
  77. Maurer D, Felzmann T, Holter W, Petera P, Smolen J, Knapp W. Evidence for the presence of activated CD4 T cells with naive phenotype in the peripheral blood of patients with rheumatoid arthritis. Clinical and Experimental Immunology. 1992;87(3):429–434
  78. Marcenaro M, Prete C, Badini A, Sulli A, Magi E, Cutolo M. Rheumatoid arthritis, personality, stress response style, and coping with illness: a preliminary survey. Annals of the New York Academy of Sciences. 1999;876:419–425
  79. Martin L. Rheumatoid arthritis: symptoms, diagnosis, and management. Nursing Times. 2004;100(24):40–44
  80. McCann SM, Kimura M, Karanth S, Yu WH, Mastronardi CA, Rettori V. The mechanism of action of cytokines to control the release of hypothalamic and pituitary hormones in infection. Annals of the New York Academy of Sciences. 2000;917:4–18
  81. McCurdy D. Genetic susceptibility to the connective tissue diseases. Current Opinion in Rheumatology. 1999;11(5):399–407
  82. Miossec P. An update on the cytokine network in rheumatoid arthritis. Current Opinion in Rheumatology. 2004;16(3):218–222
  83. Miyata M, Sato Y, Kasukawa R. IgG 1 subclass specificity for IgG rheumatoid factors in patients with rheumatoid arthritis. Journal of Rheumatology. 1999;26(7):1436–1438
  84. Morel PA, Fathman CG. Immunogenetics of rheumatoid arthritis. Journal of Rheumatology. 1989;16(4):421–423
  85. Mouritsen S. Rheumatoid factors are anti-idiotypic antibodies against virus induced anti-Fc receptor antibodies: a hypothesis for the induction of some rheumatoid factors. Scandinavian Journal of Immunology. 1986;24(5):485–490
  86. Nepom GT, Byers P, Seyfried C, Healey LA, Wilske KR, Stage D, et al. Arthritis and Rheumatism. 1989;32(1):15–21
  87. Niki Y, Yamada H, Kikuchi T, Toyama Y, Matsumoto H, Fujikawa K, et al. Membrane-associated IL-1 contributes to chronic synovitis and cartilage destruction in human IL-1 alpha transgenic mice. Journal of Immunology. 2004;172(1):577–584
  88. Nouri AME, Panayi GS, Goodman SM. Cytokines and the chronic inflammation of rheumatic disease I. The presence of interleukin-1 in synovial fluids. Clinical and Experimental Immunology. 1984;55:295–302
  89. Ohta N, Nishimura YK, Tanimoto K, Horiuchi Y, Abe C, Shiokawa Y, et al. Association between HLA and Japanese patients with rheumatoid arthritis. Human Immunology. 1982;5(1):23–132
  90. Okamoto K, Makino S, Yoshikawa Y, Takaki A, Nagatsuka Y, Ota M, et al. Identification of I kappa BL as the second major histocompatibility complex-linked susceptibility locus for rheumatoid arthritis. American Journal of Human Genetics. 2003;72(2):303–312
  91. Oppenheim JJ, Ruscetti FW, Faltynek C. In:  Stites DP,  Terr AI editor. Basic and clinical immunology. seventh ed.. Norwalk, CT: Appleton & Lange; 1991;p. 78–100
  92. Oppliger IR, Nardella FA, Stone GC, Mannik W. Human rheumatoid factors bear the internal image of the Fc binding region of staphylococcal protein A. Journal of Experimental Medicine. 1987;166(5):702–710
  93. Panayi GS, Wooley P, Batchelor JP. Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. British Medical Journal. 1978;2:1326–1328
  94. Parslow TG. Immunoglobulin genetics. In:  Stites DP,  Terr AI editor. Basic and clinical immunology. seventh ed.. Norwalk, CT: Appleton & Lange; 1991;p. 122–130
  95. Rankin JA. Pathophysiology of the rheumatoid joint. Orthopaedic Nursing. 1995;14(4):39–46
  96. Rankin JA. Biological mediators of acute inflammation. American Association of Critical-Care Nurses (AACN) Clinical Issues. 2004;15(1):3–17
  97. Res PCM, Telgt D, Van Laar JM, Pool MO, Breedveld FC, de Vries RRP. High antigen reactivity in mononuclear cells from sites of chronic inflammation. Lancet. 1990;336:1368–1372
  98. Rodriguez MA, Williams RC. Infection and rheumatic diseases. Clinical and Experimental Rheumatology. 1989;7(1):91–97
  99. Roitt IM, Hutchings PR, Dawe KI, Sumar N, Bodman KB, Cooke A. The forces driving autoimmune disease. Journal of Immunology. 1992;5(Suppl. A):11–26
  100. Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA. Proposed diagnostic criteria for rheumatoid arthritis. Bulletin of Rheumatic Disease. 1956;7(1):121–124
  101. Rook G, McCulloch J. HLA-DR4, mycobacteria, heat shock proteins and rheumatoid arthritis. Arthritis and Rheumatism. 1992;35(12):1409–1412
  102. Saint-Ruf C, Lechner O, Feinberg J, von Boehmer H. Genomic structure of the human pre-T cell receptor alpha chain and expression of two mRNA isoforms. European Journal of Immunology. 1998;28(11):3824–3831
  103. Schiffenbauer J, Schwartz BD. The HLA complex and its relationship to rheumatic diseases. Rheumatic Disease Clinics of North America. 1987;13(3):463–485
  104. Schwab W, Gavlik JM, Beichler T, Funk RH, Albrecht S, Magdolen V, et al. Expression of the urokinase-type plasminogen activator receptor in human articular chondrocytes: association with caveolin and beta 1-integrin. Histochemistry and Cell Biology. 2001;115(4):317–323
  105. Schwimmbeck PL, Yu DTY, Oldstone MBA. Autoantibodies to HLA-B27 in the sera of HLA-B27 patients with ankylosing spondylitis and Reiter’s syndrome – Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease. Journal of Experimental Medicine. 1987;166(1):173–181
  106. Scriver CR. Translating knowledge into practice in the post-genome era. Acta Paediatrica. 2004;93(3):294–300
  107. Shanahan JC, Moreland LW, Carter RH. Upcoming biologic agents for the treatment of rheumatic diseases. Current Opinion in Rheumatology. 2003;15(3):226–236
  108. Silman AJ. The genetic epidemiology of rheumatoid arthritis. Clinical and Experimental Rheumatology. 1992;10(3):309–312
  109. Silman AJ, Pearson JE. Epidemiology and genetics of rheumatoid arthritis. Arthritis Research. 2002;4(Suppl. 3):S265–S272
  110. Silman A, Symmons D, Scott DG, Griffiths I. British Society for Rheumatology Biologics Register. Annals of the Rheumatic Diseases. 2003;62(Suppl. 2):ii28–ii29
  111. Smith CA, Arnett FC. Epidemiologic aspects of rheumatoid arthritis. Clinical Orthopaedics. 1991;265:23–35
  112. Smith DA, Germolec DR. Introduction to immunology and autoimmunity. Environmental Health Perspectives. 1999;107(Suppl. 5):661–665
  113. Stastny P. Association of the B cell alloantigen DRw4 with rheumatoid arthritis. New England Journal of Medicine. 1978;298(16):869–871
  114. Stites DP, Terr AI. Basic human immunology. Norwalk, Connecticut: Appleton & Lange; 1991;pp. 45–60
  115. Sun HB, Nalim R, Yokota H. Expression and activities of matrix metalloproteinases under oscillatory shear in IL-1-stimulated synovial cells. Connective Tissue Research. 2003;44(1):42–49
  116. Tan PLJ, Skinner MA. The microbial cause of rheumatoid arthritis: time to dump Koch’s postulates. Journal of Rheumatology. 1992;19(8):1170–1171
  117. Terr AI. Mechanisms of inflammation. In:  Stites DP,  Terr AI editor. Basic and clinical immunology. seventh ed.. Norwalk, CT: Appleton & Lange; 1991;p. 131–140
  118. Tiwana H, Wilson C, Alvarez A, Abuknesha R, Bansal S, Ebringer A. Cross-reactivity between the rheumatoid arthritis-associated motif EQKRAA and structurally related sequences found in Proteus mirabilis. Infection and Immunity. 1999;67(6):2769–2775
  119. Tiwana H, Natt RS, Benitez-Brito R, Shah S, Wilson C, Bridger S, et al. Correlation between the immune responses to collagens type I, III, IV and V and Klebsiella pneumoniae in patients with Crohn’s disease and ankylosing spondylitis. Rheumatology. 2001;40(1):15–23
  120. Toivanen P. From reactive arthritis to rheumatoid arthritis. Journal of Autoimmunity. 2001;16(3):369–371
  121. Torrey EF, Yolken RH. The schizophrenia-rheumatoid arthritis connection: infectious, immune, or both?. Brain Behavior and Immunity. 2001;15(4):401–410
  122. Trull A, Ebringer A, Panayi G, Ebringer R, James DCO. HLA-B27 and the immune response to enterobacterial antigens in ankylosing spondylitis. Clinical and Experimental Immunology. 1984;55(1):74–80
  123. Tsuchiya N, Husby G, Williams RC. Studies of humoral and cell-mediated immunity to peptides shared by HLA-27.1 and Klebsiella pneumoniae nitrogenase in ankylosing spondylitis. Clinical and Experimental Immunology. 1989;76(3):354–360
  124. Tsuchiya N, Williams RC, Hutt-Fletcher LM. Rheumatoid factors may bear the internal image of the Fc g binding protein of herpes simplex virus type I. Journal of Immunology. 1990;144(12):4742–4748
  125. Tsuchiya N, Williams RC. Molecular mimicry – Hypothesis or reality?. Western Journal of Medicine. 1992;157(2):133–138
  126. Van Eden W, Thole JER, Van der Zee R, Noordzij A, Van Embden JDA, Hensen EJ, et al. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature. 1988;331(6152):171–173
  127. Van der Pouw Kraan TC, van Gaalen FA, Huizinga TW, Pieterman E, Breedveld FC, Verweij CL. Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: evidence for the existence of multiple pathways of tissue destruction and repair. Genes and Immunity. 2003;4(3):187–196
  128. Van der Zee R, Van Eden W, Maloen RH, Noordzij A, Van Embden JDA. Efficient mapping and characterization of a T cell epitope by the simultaneous synthesis of multiple peptides. European Journal of Immunology. 1989;19(1):43–47
  129. Waksman BH. Immune regulation in adjuvant disease and other arthritis models: relevance to pathogenesis of chronic arthritis. Scandinavian Journal of Immunology. 2002;56(1):12–34
  130. Weyand CM, Oppitz U, Hicok K, Goronzy JJ. Selection of T cell receptor VB elements by HLA-DR determinants predisposing to rheumatoid arthritis. Arthritis and Rheumatism. 1992;35(9):990–998
  131. Wilder RL, Crofford LJ. Do infectious agents cause rheumatoid arthritis?. Clinical Orthopaedics. 1991;265:36–41
  132. Willkens RF, Nepom GT, Marks CA, Nettles JW, Nepom BS. Association of HLA-Dw16 with rheumatoid arthritis in Yakima Indians. Arthritis and Rheumatism. 1991;34(1):43–47
  133. Wong T, Majchrzak B, Bogoch E, Keystone EC, Fish EN. Therapeutic implications for interferon-α in arthritis: a pilot study. Journal of Rheumatology. 2003;30(5):934–940

PII: S1361-3111(05)00016-6

doi: 10.1016/j.joon.2005.02.001

Journal of Orthopaedic Nursing
Volume 9, Issue 2 , Pages 64-76 , May 2005

Article Tools

* Image Usage & Resolution